Vox Markets Logo

Entain's share-price weakness overdone, says Citi

10:29, 11th January 2024

(Sharecast News) - Citi has resumed coverage of Entain Plc (ENT) Follow | ENT with a 'buy' rating, saying it see upside potential from the gambling group's US operations.
Despite an 18% gain in the past month, shares the Ladbrokes owner have fallen by more than a third over the past year.

In August 2023, the stock took a tumble after its US joint venture (JV) partner MGM Resorts announced plans to launch a UK online betting site, while the company has disappointed with updates about falling online net gaming revenue (NGR). That culminated with the resignation of chief executive Jette Nygaard-Andersen in December.

"Our [sum-of-the-parts] framework suggests no value is being ascribed to ENT's 50% stake in BetMGM (US JV), which we see as overly negative given recent changes to ENT's management (CEO step down), shareholder register (activist investors), and board (Eminence founder now [non-executive director]), which we think is likely to increase ENT's receptiveness to value-unlock opportunities," Citi said in a research note on Thursday.

"We are cautious on its ex-US business with our FY24 revenue estimate at the low-end of guidance, but acknowledge market expectations have been rebased following Entain's downgrades to online NGR growth and expect recovery to be led by UK, Australia, Brazil."

The stock was up 1% at 961.2p by 0953 GMT.

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
  • London close: Stocks rise as US payrolls come in weaker

    2 days ago

    London markets closed positively on Friday, as investors digested slower-than-expected payrolls growth in the US, while Anglo American jumped amid anticipation of a potential bidding war for the mining giant.

  • FTSE 250 movers: Trainline rolling; Georgia banks out of favour

    2 days ago

    FTSE 250 (MCX) 20,198.09 0.73%

  • FTSE 100 movers: Anglo rallies on Reuters report; IHG slumps

    2 days ago

    London's FTSE 100 was up 0.5% at 8,209.34 in afternoon trade on Friday.

  • Berenberg raises target price on Standard Chartered

    3 days ago

    Analysts at Berenberg raised their target price on multinational bank Standard Chartered from 1,050.0p to 1,100.0p on Friday after the group's Q1 earnings "validated" management's suggestion that the bank had experienced "an encouraging start" to the year.

  • Citi sees significant upside at Team17

    3 days ago

    Citi has reiterated its 'buy' rating for British video-game developer Team17, saying it sees significant upside to its valuation as operations stabilise.

  • Jefferies downgrades AJ Bell after share price rally

    3 days ago

    Jefferies downgraded its stance on AJ Bell on Friday to 'hold' from 'buy' after a circa 30% rally in the shares this year.

  • Triple Point to sell part of portfolio after shareholder consultation

    3 days ago

    Triple Point Social Housing announced plans to sell part of its portfolio on Friday, following shareholder consultations.

  • Adriatic Metals announces resignation of CFO

    3 days ago

    Adriatic Metals, the FTSE 250 precious and base metals miner, has announced that its chief financial officer is stepping down after just two years on the job.

  • CMA set for deeper probe of Pennon's SES acquisition

    3 days ago

    Pennon Group worked to assure the market that its acquisition of Sutton and East Surrey Water (SES Water) would avoid a deeper competition probe on Friday, telling shareholders that it planned to offer "appropriate undertakings" to regulators.

  • Angle strikes supplier deal with AstraZeneca

    3 days ago

    Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Watchlist